Metagenomi Therapeutics (MGX) Return on Capital Employed [ROCE] (2024 - 2026)
Metagenomi Therapeutics (MGX) reported Return on Capital Employed [ROCE] of -63.77% for Q2 2026, down 27.31 percentage points from -36.46% a year earlier and down 14.03 percentage points from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends
For FY2025, Metagenomi Therapeutics posted Return on Capital Employed [ROCE] of -38.42%, down 9.50 percentage points from FY2024.
- By year, Return on Capital Employed [ROCE] came in at -28.92% in FY2024.
- The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2024.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last six quarters, with an average year-over-year change of -14.85 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -49.74% (Q1 2026), -45.38% (Q4 2025) and -40.03% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.86% |
| 10 | Metagenomi Therapeutics | 30.49 Mn | -575.25 Mn | - | -63.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.77% |
| Mar 31, 2026 | -49.74% |
| Dec 31, 2025 | -45.38% |
| Sep 30, 2025 | -40.03% |
| Jun 30, 2025 | -36.46% |
| Mar 31, 2025 | -32.32% |
| Dec 31, 2024 | -29.23% |
| Sep 30, 2024 | -27.10% |
| Jun 30, 2024 | -25.44% |
| Mar 31, 2024 | -28.05% |
API Access
Metagenomi Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();